Moreover, it was found that high HNF4A-AS1 expression is associated with MYCN amplification in neuroblastoma tumors and that MYCN overexpression or knockdown in neuroblastoma cell lines increases or downregulates HNF4A-AS1 expression, respectively [69]. This evidence concerns the gene PTGDR and neuroblastoma.